Financhill
Back

Nxera Pharma Co., Ltd. 10K Form

Sell
18

SOLTF
Nxera Pharma Co., Ltd.

Last Price:
$5.00
Seasonality Move:
12.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOLTF News And Ratings

See the #1 stock for the next 7 days that we like better than SOLTF

SOLTF Financial Statistics

Sales & Book Value

Annual Sales: $190.3M
Cash Flow: $-20.9M
Price / Cash Flow: 57.47
Annual Sales: $4.91
Price / Book: 1.02

Profitability

EPS (TTM): -0.46090
Net Income (TTM): $-41.5M
Gross Margin: $119.7M
Return on Equity: -9.2%
Return on Assets: -4.17%

Nxera Pharma Co., Ltd. Earnings Forecast

Key Nxera Pharma Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 22 years for SOLTF is 62.87%.
  • The Selling, General & Administrative Expenses for SOLTF have been equal to 55.54% of Gross Profit Margin.
  • The Research & Development expenses have been 40.98% of Revenue.
  • The Net Earning history of SOLTF is -16.78% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 10 years.

Nxera Pharma Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: SOLTF
Website: nxera.life

Debt

Debt-to-Equity Ratio: 0.96
Current Ratio: 3.14
Quick Ratio: 2.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOLTF Technical Analysis vs Fundamental Analysis

Sell
18
Nxera Pharma Co., Ltd. (SOLTF) is a Sell

Is Nxera Pharma Co., Ltd. a Buy or a Sell?